Evidence-Based Medicine Guidelines
Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH)
Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk for Heparin-induced Thrombocytopenia (HIT) With Either Low-molecular-weight Heparin (LMWH) or Unfractionated Heparin (UFH)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455238/all/_________Risk_for_heparin_induced_thrombocytopenia__HIT__with_either_low_molecular_weight_heparin__LMWH__or_unfractionated_heparin__UFH_______.
Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455238/all/_________Risk_for_heparin_induced_thrombocytopenia__HIT__with_either_low_molecular_weight_heparin__LMWH__or_unfractionated_heparin__UFH_______. Accessed November 28, 2022.
Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH). (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455238/all/_________Risk_for_heparin_induced_thrombocytopenia__HIT__with_either_low_molecular_weight_heparin__LMWH__or_unfractionated_heparin__UFH_______
Risk for Heparin-induced Thrombocytopenia (HIT) With Either Low-molecular-weight Heparin (LMWH) or Unfractionated Heparin (UFH) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 November 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455238/all/_________Risk_for_heparin_induced_thrombocytopenia__HIT__with_either_low_molecular_weight_heparin__LMWH__or_unfractionated_heparin__UFH_______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH)
ID - 455238
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455238/all/_________Risk_for_heparin_induced_thrombocytopenia__HIT__with_either_low_molecular_weight_heparin__LMWH__or_unfractionated_heparin__UFH_______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
